← All diseases Infectious diseases

Drug-resistant tuberculosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (60)Meta-analysis (18)Treatment guideline (2)Phase 3 study (14)Systematic review (13)Randomized controlled trial (13)Clinical trial (160)Review article (219)Early Study (Phase 1 or 2) (10)Case report (62)Laboratory or animal study (27)Commentary or editorial (27)Retracted publication (1) Studies currently recruiting participants only (23)

Filter

Publications and studies (1454)

• The unique role of nucS-mediated noncanonical mismatch repair in Mycobacterium tuberculosis resistance evolution. (2026/02/11) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Types and Severity of Hearing Loss among Patients with Tuberculosis receiving Anti-Tuberculosis Treatment in Nigeria: A Single Center Study. (2026/02/04) ♡
• Molecular epidemiology of drug resistance and transmission of Mycobacterium tuberculosis in Meigu County, Sichuan Province, China. (2026/02/03) ♡
• Integrating structure-guided and fragment-based inhibitor design to combat bedaquiline resistant Mycobacterium tuberculosis: a molecular dynamics study. (2026/02/01) ♡
• Synthesis, antitubercular activity and computational studies of click-tethered phosphonium salts. (2026/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent developments in diagnosis of Mycobacterium tuberculosis: an overview. (2026/02/01) ♡
• Interaction of isoniazid derivatives active against drug-resistant tuberculosis with models of the lung surfactant and of the Mycobacterium tuberculosis cell wall. (2026/02/01) ♡
• Role of efflux pump inhibitors in enhancing the effect of bedaquiline on M. tuberculosis. (2026/02/01) ♡
• Prevalence of Vitamin D Deficiency in Pulmonary Tuberculosis: A Prospective Cross-sectional Study. (2026/02/01) ♡
• Metagenomic and metatranscriptomic profiling of bronchoalveolar lavage fluid identifies microbial and host biomarkers of drug-resistant tuberculosis. (2026/01/29) ♡
• Barriers and Enablers to All-Oral Multi-Drug Resistance Tuberculosis Treatment Adherence in Traditional Authorities Chimwala and Chowe, Mangochi District, Malawi. (2026/01/29) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pediatric Tuberculosis: Unraveling Immunity, Clinical Complexities, and Resource-Driven Disparities in the Pursuit of Prevention. (2026/01/27) ♡
• RNA anti-CRISPRs deplete Cas proteins to inhibit the CRISPR-Cas system. (2026/01/22) ♡
• The microevolutionary trajectory of endemic multidrug-resistant tuberculosis strains in Portugal toward increased drug resistance levels and its clinical significance. (2026/01/21) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Functional analysis of two component signaling system in Mycobacterium tuberculosis. (2026/01/20) ♡
• Success rates of DR-TB patients and associated factors in Tanzania: a six-year cohort study. (2026/01/20) ♡
• Effects of mutations in multiple Ethionamide-resistance-associated genes among Mycobacterium tuberculosis clinical isolates from China. (2026/01/16) ♡
• Tuberculosis prevention in children, adolescents, and pregnant and postpartum women in South Africa. (2026/01/16) ♡
• Overview of Tuberculosis Cases Reported in 2024 in the Capital Region: Seoul Metropolitan City, Incheon Metropolitan City, Gyeonggi-do, and Gangwon State. (2026/01/15) ♡
• Diet and nutrition status of adult multidrug-resistant tuberculosis cases, household controls, and community controls in Mumbai, India. (2026/01/13) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Research progress on protein tyrosine phosphatase A from Mycobacterium tuberculosis. (2026/01/12) ♡
• Discovery and Optimization of Phenoxazinone Derivatives as Potent Antitubercular Agents Targeting FabD Protein. (2026/01/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Assessment of the efficacy of plant-derived essential oils against Mycobacterium tuberculosis: A systematic review and meta-analysis. (2026/01/07) ♡
• Combinatorial Therapy of Nanoformulation with Herbal Medicine to Circumvent Fungal Diseases. (2026/01/02) ♡
• Immunoinformatics-driven design of a multi-epitope vaccine targeting non-typhoidal Salmonella's type IV secretion system VirB4, VirB5, and VirB6 proteins. (2026/01/01) ♡
• The bedaquiline market for drug-resistant tuberculosis treatment and the challenges for public production in Brazil. (2026/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting Mycobacterium tuberculosis F(420)-dependent dehydrogenases for new anti-tubercular drug discovery. (2026/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Understanding the experiences and needs of patients with MDR/XDR-TB: A qualitative metasynthesis. (2026/01/01) ♡
• A diagnostic study of pulmonary and extra pulmonary tuberculosis by GeneXpert MTB/RIF assay in pediatric population. (2026/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tuberculosis: An Ongoing Global Threat. (2026/01/01) ♡
• Epidemiology and outcomes of multidrug-resistant tuberculosis in Rwanda. (2026/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study. (2026/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Development and Validation of the Nurse Unit Manager Competency Scale (NUM-CS): A Multicenter Study. (2026/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Training Protocol on the Natural History of Tuberculosis. (2026-08-07) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis. (2026-07-24) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis. (2026-07-15) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB (2026-07-06) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB (2026-07-06) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment (2026-07-02) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis (2026-06-01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. An Adaptive Randomized Controlled Trial (2026-05-28) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis (2026-05-20) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment (2026-05-13) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis (2026-05-06) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis (2026-05-06) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis (2026-05-04) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Linezolid Dosing Strategies in Drug-Resistant TB (2026-05-01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR) (2026-03-20) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Treatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug Resistance (2026-03-17) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Bioneer Q-RFIA Clinical Evaluation (2026-02-09) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.